GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep …
2 days ago · On Thursday, GSK plc (NYSE:GSK) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase 3 trial of Blenrep (belantamab mafodotin) in combination with ...
GSK reports positive outcomes from Phase III multiple myeloma …
2 days ago · GSK has announced positive headline interim analysis outcomes from a Phase III trial, which is evaluating Blenrep (belantamab mafodotin) along with bortezomib and dexamethasone (BorDex) for ...
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep
2 days ago · The DREAMM-7 trial showed Blenrep with BorDex lowered death risk in relapsed/refractory multiple myeloma vs. standard treatment. A phase 3 study in newly diagnosed transplant-ineligible multiple ...
Bordeaux Breaking News Headlines Today - Ground News
6 days ago · Stay current with all the latest and breaking news about Bordeaux, compare headlines and perspectives between news sources on stories happening today. In total, 495 stories have been published about Bordeaux which Ground News has aggregated in …
GSK Reports Positive Headline Results From DREAMM-7 Phase III …
3 days ago · Nov. 14, 2024, 02:30 AM. (RTTNews) - GSK plc (GSK, GSK.L), on Thursday, announced positive headline results from a planned interim analysis of the DREAMM-7 head-to-head phase III trial evaluating ...
GSK announces Blenrep met key secondary endpoint in DREAMM …
3 days ago · GSK (GSK) announced positive headline results from a planned interim analysis of the DREAMM-7 head-to-head phase III trial evaluating Blenrep in combination with bortezomib plus dexamethasone as a ...
China grants BTD to Blenrep with BorDex for multiple myeloma
Sep 16, 2024 · China’s National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) has granted breakthrough therapy designation (BTD) for GSK ‘s Blenrep (belantamab mafodotin) combined with bortezomib plus dexamethasone (BorDex) for the treatment of relapsed or refractory multiple myeloma.
Bordeaux - The Local
Latest news and important information from Bordeaux. Travel news. What will happen to flights from Bordeaux airport after Ryanair leaves? Environment 4. Bordeaux mayor seeks to ban cruise...
GSK files Blenrep in EU, seeking return to market - pharmaphorum
Jul 19, 2024 · The marketing application to the EMA covers Blenrep (belantamab mafodotin) in combination with bortezomib plus dexamethasone (BorDex) or pomalidomide plus dexamethasone (PomDex) as a treatment...
Bordeaux - BBC News
Feb 25, 2024 · Bordeaux's Elis in induced coma after head injury. Bordeaux striker Alberth Elis is in an induced coma after suffering a serious head injury in a collision with an opponent. European...